Taxation News and Research

RSS

Fitch Ratings announces Covidien rating outlook stable

Fitch Ratings has affirmed Covidien plc's (Covidien) ratings.

19 Dec 2009

Medical Marijuana purchases 20 acres of prime mountain valley property in Southern California

Medical Marijuana, Inc. announces today the purchase of 20 acres of prime mountain valley property in Southern California intended to be used within strict governmental guidelines as a research facility targeting medical Cannabis strains specific to a wide range of medical conditions.

14 Dec 2009

WellPoint's NextRx subsidiaries acquired by Express Scripts

Express Scripts, Inc., and WellPoint, Inc., announced today the closing of Express Scripts' acquisition of WellPoint's NextRx subsidiaries.

1 Dec 2009

Andor Technology reports 2009 preliminary results

ANDOR TECHNOLOGY PLC ("Andor") Preliminary Results for the year ended 30 September 2009 24 November 2009 Andor Technology plc (AND.L), the leading developer and manufacturer of high performance digital cameras and solutions for academic, industrial and government applications globally, today announces preliminary results for the year ended 30 September 2009.

24 Nov 2009

Senators prepare for upcoming health reform battles

The Wall Street Journal reports that, in a party-line vote Saturday night, "Democratic leaders finally moved their sweeping health bill to the Senate floor, where wheeling and dealing over major unresolved and divisive issues likely will shape the legislation before its next big test." Some centrists are busy saying they won't support a bill with a government-run public option in it. They are also divided over abortion.

23 Nov 2009

5% tax on cosmetic surgery opposed by AAFPRS

The United States Senate is about to consider health system reform legislation which contains a 5% tax on cosmetic surgery deemed unnecessary for medical purposes. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) announces it strongly opposes the inclusion of this tax as it is discriminatory and has already failed in other states.

20 Nov 2009

CMS report: House bill will raise health care costs, affect seniors' benefits

A new report from the Centers for Medicare and Medicaid Services finds that the health overhaul bill passed by the House will raise health costs by approximately $289 billion in the next ten years. The report was requested by House Republicans and compiled by CMS' chief actuary, Richard Foster.

16 Nov 2009

CMS report on House health bill: Many more insured means more, not less, spending

The Associated Press: "Overall spending on health care would rise as a result of legislation approved a week ago by the House, and billions of dollars in projected savings contained in the measure will be difficult to maintain, according to a report by a top official at the agency that oversees Medicare.

16 Nov 2009

USAction hails passage of the Affordable Health Care for America Act

USAction this evening hailed passage of the Affordable Health Care for America Act, which will make health care more affordable for consumers, hold insurance companies accountable and increase access to health care for millions of Americans through a public option.

9 Nov 2009

Smith & Nephew reports third quarter 2009 financial results

Smith & Nephew Q3 Results - continued strong profit performance 6 November 2009 Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces its results for the third quarter ended 26 September 2009.

6 Nov 2009

USAction urges House to pass comprehensive health care reform legislation

The Affordable Health Care for America Act will make health care more affordable for consumers, hold insurance companies accountable and increase access to health care for millions of Americans.

6 Nov 2009

CBO: House health bill would lower some middle class premiums, raise costs for others

House Democrats say their health overhaul proposal will lead to health insurance premium savings for many consumers, though estimates of the overall measure's cost, as well as the taxes and fees required to pay for it, is a source of criticism and concern.

3 Nov 2009

Many details still bedevil Democrats in health reform bills

It was the usual partisan squabbling on the Sunday talk shows today, while Democrats are braced for a significant week ahead, ironing out significant differences in various health reform bills.

1 Nov 2009

Shire announces third quarter 2009 financial results

Shire plc, the global specialty biopharmaceutical company, announces results for the three months to September 30, 2009.

31 Oct 2009

Allergan reports operating results for the third quarter of 2009

Allergan, Inc. today announced operating results for the quarter ended September 30, 2009. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on November 30, 2009 to stockholders of record on November 9, 2009.

29 Oct 2009

Wellpoint announces third quarter 2009 financial results; net income is 1.53 per share

WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2009 net income was $730.2 million, or $1.53 per share, including net investment gains of $21.5 million pre-tax, or $0.03 per share, and an impairment charge totaling $205.5 million pre-tax, or $0.28 per share, for certain intangible assets.

28 Oct 2009

Microbix and Hunan Biopharmaceutical to build $200-million influenza vaccine facility

Microbix, a developer of a patented technology that doubles the output of influenza vaccine production, announced today it has signed a joint venture agreement with the Hunan Biopharmaceutical Co. Ltd. (a Hunan Province state-owned enterprise) for initial financing to construct Asia's largest influenza vaccine production facility and the third largest vaccine plant in the world.

28 Oct 2009

Medical Marijuana commences multi-industry implementation of its tax remittance solution

Medical Marijuana Inc has entered into discussions with a publicly traded coffee distribution company for licensing of its patent pending tax remittance solution. Medical Marijuana Inc's tax remittance technology was originally designed to be industry and product neutral; it can be implemented in any industry.

22 Oct 2009

Pfizer announces fiscal 2009 third-quarter results

Pfizer Inc. today reported financial results for third-quarter 2009. Revenues were $11.6 billion, a decrease of 3% compared with $12.0 billion in the year-ago quarter.

20 Oct 2009

Medical Marijuana offers "Turnkey Collective Solution" for collectives to conform to state laws

Medical Marijuana, Inc. is the ONLY company that provides the specific solutions the government is seeking in order for all collectives and co-ops to be in total compliance with state laws and city/county ordinances. Their revolutionary patent pending Tax Remittance Card and patent pending Inventory Management System and Supply Chain Network provides all of the tools necessary for regulatory authorities and industry operators alike to manage compliance efficiently and effectively.

20 Oct 2009